The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Improving Health Outcomes Of Preterm Newborns In Low- And Middle-income Countries
Funder
National Health and Medical Research Council
Funding Amount
$1,562,250.00
Summary
Preterm birth (being born too soon) affects 1 in 10 births worldwide. In many low-income countries, preterm babies die for lack of effective care around the time of childbirth. My research aims to answer whether medicines such as steroid injections (to develop the baby’s lungs) and tocolytics (drugs to slow down or stop labour) actually help preterm babies born in low-income countries. I will also find ways to better measure how many women experience preterm birth in low-middle income countries.
An Imaging-genomic Approach To Advance Understanding Of Early Cortical Development And Outcome After Preterm Birth
Funder
National Health and Medical Research Council
Funding Amount
$645,205.00
Summary
In Australia, over 26,000 babies are born too early each year, with long-lasting consequences to their development. We do not know how preterm birth affects the newborn brain. In order to improve our understanding, I will combine neuroimaging and genetic data to uncover how preterm birth affects the development of the brain in newborns and how this imparts risk for poor cognitive and motor outcomes. This will allow us better plan and monitor clinical trials and treatments for these infants.